|
|
Volumn 53, Issue 3, 2002, Pages 284-295
|
|
Levormeloxifene: Safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator
a
|
|
Author keywords
Antiatherogenic properties; Bone metabolism; Collagen I C terminal telopeptide; Healthy postmenopausal women; Levormeloxifene; Multiple dose trial; Pharmacokinetics; Safety; Selective oestrogen receptor modulator; Single dose trial
|
|
Indexed keywords
CENTCHROMAN;
CHOLESTEROL;
COLLAGEN TYPE 1;
FOLLITROPIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
LUTEINIZING HORMONE;
PLACEBO;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TRIACYLGLYCEROL;
ABDOMINAL PAIN;
ADULT;
AGED;
ARTICLE;
BLOOD SAMPLING;
BONE METABOLISM;
BONE TURNOVER;
CHOLESTEROL BLOOD LEVEL;
CLINICAL CHEMISTRY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG ACCUMULATION;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG ELIMINATION;
DRUG SAFETY;
DRUG TOLERABILITY;
ELECTROCARDIOGRAM;
FEMALE;
HEADACHE;
HEMATOLOGY;
HUMAN;
HYPOTHALAMUS HYPOPHYSIS SYSTEM;
LEUKORRHEA;
LIPID METABOLISM;
MAJOR CLINICAL STUDY;
PLASMA HALF LIFE;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
AGED;
AREA UNDER CURVE;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MIDDLE AGED;
OSTEOPOROSIS, POSTMENOPAUSAL;
POSTMENOPAUSE;
PYRROLIDINES;
RECEPTORS, ESTROGEN;
TREATMENT OUTCOME;
|
|
EID: 0036122631
PISSN: 03065251
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0306-5251.2001.01181.x Document Type: Article |
|
Times cited : (15)
|
|
References (23)
|
